Close Menu
Savannah HeraldSavannah Herald
    • Home
    • News
      • Local
      • State
      • National
      • World
      • HBCUs
    • Events
    • Directories
    • Weather
    • Traffic
    • Jobs
    • Sports
    • Politics
    • Lifestyle
      • Faith
      • Senior Living
      • Health
      • Travel
      • Beauty
      • Fashion
      • Food
      • Art & Literature
    • Business
      • Real Estate
      • Entertainment
      • Investing
      • Education
    • Guides
      • SSU Homecoming Guide
      • Back to School Savannah
      • Summer Camp Guide
      • Juneteenth Guide
      • Black History Savannah
      • MLK Guide Savannah
    We're Social
    • Twitter
    • Facebook
    • YouTube

    Subscribe to Updates

    Get the latest creative news from FooBar about art, design and business.

    Trending
    • How to Negotiate Price on a New Construction Home in 2026
    • Historic Mitchelville on Hilton Head Island, SC gets new life for new generations
    • Lynchburg to host virtual lecture by chieftess of Gullah/Geechee Nation
    • ‘I ain’t goin nowhere’: Gullah Geechee people fight off developers with a historic referendum | Gullah Geechee
    • “She a Real Dawg”: Ex-NBA Player’s Daughter Earns Flau’jae Johnson’s Praise After Dominant UNC Performance
    • Carrie B. “Mama” Cunningham (1890–1973)
    • Georgia Watch Honors 2026 Consumer Champions
    • Eagles Wrap Up 2026 Season at NCAA South Regional Championships
    Facebook X (Twitter) Instagram YouTube
    Login
    Savannah HeraldSavannah Herald
    Savannah HeraldSavannah Herald
    Home » Medical Journal Retracts Study Claiming Cancer Therapy Is More Effective When Given in the Morning
    Investing

    Medical Journal Retracts Study Claiming Cancer Therapy Is More Effective When Given in the Morning

    Savannah HeraldBy Savannah HeraldJune 26, 20266 Mins Read
    Facebook Twitter Pinterest LinkedIn WhatsApp Reddit Tumblr Email
    Medical Journal Retracts Study Claiming Cancer Therapy Is More Effective When Given in the Morning
    Share
    Facebook Twitter LinkedIn Pinterest Email

    Business Briefing: Economic Updates and Industry Insights

    Key takeaways
    • Nature Medicine retracted the paper, citing multiple inconsistencies and a loss of confidence in the study's integrity.
    • Journal noted altered locked records, protocol translation discrepancies, no expected dropouts, and unusual timing patterns in follow-up scans.
    • Dr. Toni Choueiri and other oncologists helped lead a post-publication review that prompted the retraction.
    • Independent analyses found weak biological rationale and potential selection bias; debate over research reliability in China continues.

    Early this year, a medical journal article caught the attention of cancer patients and doctors worldwide because of its extraordinary conclusion. Simply changing the time of day that immunotherapy was administered appeared to produce a stunning benefit for lung cancer patients.

    Those who received IV infusions in the morning had their cancer kept at bay for twice as long as those who got it in the afternoon, according to the results from a clinical trial in China and published in the journal Nature Medicine in February. The study also reported that the patients lived nearly twice as long.

    Several oncologists said that in recent months they and their hospitals had received a flurry of calls from patients inquiring about switching to morning infusions.

    But on Wednesday, Nature Medicine retracted the study, citing a list of inconsistencies and irregularities in the trial’s design and results.

    “It was too good to be true,” said Dr. Toni Choueiri, an oncologist at the Dana-Farber Cancer Institute in Boston who helped conduct the post-publication review that led to the retraction.

    Among the issues that the journal cited in its retraction notice: Records that were supposed to be locked before the study started were changed midway through. There were discrepancies between the Chinese version of the study’s plan and the translated version. Every patient remained treated and tracked in the study’s first year, and no one dropped out because of side effects — highly unusual in an oncology study. And unusual patterns were found in the timing of follow-up scans.

    “Due to the amount and nature of the problems identified, the editors no longer have confidence in the integrity of the results,” the journal said.

    Most of the study’s 28 authors were in China, with several collaborators in Europe. The study was funded by the Chinese government.

    China has been pumping money into its hospitals and drug companies, fueling a surge of patents, publications and new clinical trials. In just a few years, the country has rapidly transformed into a powerhouse in drug development, a shift that some U.S. officials, doctors and executives see as a threat to longstanding American dominance in the field.

    China’s critics often question the reliability of its biomedical research. Experts said that, similar to studies in the United States, China’s research output spans a wide range in quality: Some Chinese scientists run their studies at the most meticulous standards. Others were said to cut corners.

    Dr. Yongchang Zhang, the study’s senior author, said in a statement that an internal review had “confirmed that part of the study execution and manuscript preparation might not reach the standards for publication in a high-impact journal.”

    Dr. Zhang, a researcher at the Chinese hospital where the study was conducted, added: “We acknowledge these shortcomings and sincerely apologize for any inconvenience caused to the journal and its readers.” He did not provide an explanation for the problems cited by the journal.

    The study had enrolled 210 patients with advanced lung cancer at Hunan Cancer Hospital in Changsha, a city in south-central China. Patients were randomly assigned to receive infusions of an immunotherapy — Merck’s blockbuster drug Keytruda or Tyvyt, which is not approved in the United States — either before or after 3 p.m.

    The study reported that tumors did not progress for 11 months in patients who received the earlier infusions, compared with six months for those given the later infusions. Patients receiving the earlier infusions lived for 28 months, compared with 17 months for those infused later in the day.

    Those “were numbers we usually associate with new blockbuster drugs, not scheduling decisions,” wrote Dr. Gilberto Lopes, an oncologist at the University of Miami. And rescheduling a patient “costs nothing,” he noted.

    Dr. Anil Makam, an epidemiologist and health services researcher at the University of California, San Francisco, said such a drastic benefit, if real, would have prompted infusion clinics to overhaul staffing and scheduling to shift appointments to earlier in the day.

    “If we believed the effects, it would be malpractice not to,” he said.

    But within days after the study’s publication in Nature Medicine, online sleuths and physicians like Dr. Makam began raising concerns on social media and in blog posts. Less than three weeks after the study was published, the journal published an editor’s note saying it was investigating the issues.

    In a statement on Thursday, Dr. João Monteiro, chief editor of Nature Medicine, which is published by Springer Nature, said, “We are grateful to the research community for bringing these concerns to our attention.”

    Some scientists have long been intrigued by the idea of harnessing the body’s circadian rhythms to try to make drugs more effective or less toxic. For example, enzymes that the body uses to break down certain medicines are more abundant at certain times of day.

    But critics of the Chinese study argued that immunotherapy works very differently from fast-acting drugs like Tylenol. The drug Keytruda lingers in the body and takes effect over several weeks. The study did not identify a biological reason for a difference in treatment timing that would produce such a significant benefit.

    “There wasn’t any sound scientific rationale behind it,” said Dr. Roy Herbst, the incoming director of the Dartmouth Cancer Center in New Hampshire and Vermont.

    In March, a team led by European researchers reported the findings of an analysis that looked at whether more than 3,000 cancer patients across eight studies had received immunotherapy in the morning or the afternoon. Their study, funded by the drugmaker Roche, which sells a number of cancer drugs, concluded that timing was “unlikely to be a critical determinant” of how well patients did.

    Other studies looking back at outcomes have found an association between the time of day that patients receive a cancer immunotherapy and how well they fare. But the why remains unclear.

    Doctors said it was possible that more energetic, healthier patients might opt for morning slots. Poorer or rural patients who live far from an infusion center — and tend to fare worse — might ask for afternoon slots because they need to spend the morning traveling to their appointment.

    Read the full article from the original source


    Related Posts

    • First Lady Melania Trump Evokes Children’s ‘Melodic Laughter’ in Personal Letter to Russia’s Putin – RedState
    • Fresh Cyberpunk 2077 patch updates AutoDrive and adds further tweaks
    • The Spiritual Factor You Awaken Worn Out Some Days.– ThyBlackMan.com
    • The ”JAŸ-Z30” Exhibits Are a Time Capsule in Hip-Hop History: Photos
    • 50 Hip-Hop, R&B Releases You Need On Your Playlist
    • What Happens to Your Body When You Eat Turkey Tail Mushroom Regularly
    • Clarence O. Smith, a Founding father of Essence Journal, Is Useless at 92
    • Some Things You Don’t Get Over
    Academic and Scientific Journals Business Development Business News Business Strategy Business Technology cancer Cancer (Journal) China Clinical Trials Company News Corporate Finance Economic Growth Economic Insights Economic Policy Entrepreneurship Financial Planning Global Economy Harvard Business Review Immune System Immunotherapy Investment Trends Leadership and Management Market Trends Nature Medicine (Journal) Research Small Business Advice Startups and Innovation Stock Market Updates Workplace Trends
    Share. Facebook Twitter Pinterest LinkedIn WhatsApp Reddit Tumblr Email
    Savannah Herald
    • Website

    Related Posts

    Investing October 22, 2026

    When You Feel Envy, Turn It Into Something Productive

    Business October 15, 2026

    Team Dynamics Weaken When Employees Turn to AI instead of Colleagues

    Health October 15, 2026

    Pope Leo is eating and walking after cancer surgery, but Latin America trip is in question

    Business October 14, 2026

    What Sets Great Strategists Apart in the AI Era

    Investing October 14, 2026

    Why Great Teams Don’t Need to Like Each Other

    Business October 13, 2026

    Restructuring Mobile Game Giant Supercell for a Turnaround

    Comments are closed.

    Don't Miss
    Local August 28, 2025By Savannah Herald03 Mins Read

    '' Some offered all ': A homage to dropped Savannah, Chatham Area police

    August 28, 2025

    Regional Voices. Statewide Influence. Keep Educated with Georgia Information SAVANNAH, Ga. (WSAV)– Savannah and Chatham…

    City-Supported Affordable Housing Development at 1700 Drayton Earns Competitive State Tax Credit • Savannah Herald

    October 13, 2026

    Today’s NYT Mini Crossword Answers for June 27

    June 26, 2026

    U.N. Gives China Seat on Human Rights Council on Anniversary of Tiananmen Square Massacre

    July 4, 2026

    The Brainwashing of White Individuals

    October 28, 2025
    Archives
    • November 2026
    • October 2026
    • September 2026
    • August 2026
    • July 2026
    • June 2026
    • May 2026
    • April 2026
    • March 2026
    • February 2026
    • January 2026
    • December 2025
    • November 2025
    • October 2025
    • September 2025
    • August 2025
    • July 2025
    • June 2025
    • May 2025
    • April 2025
    • March 2025
    • February 2025
    Categories
    • Art & Literature
    • Beauty
    • Black History
    • Business
    • Climate
    • Culture
    • Education
    • Employment
    • Entertainment
    • Faith
    • Fashion
    • Food
    • Gaming
    • Georgia Politics
    • Guides
    • HBCUs
    • Health
    • Health Inspections
    • Investing
    • Lifestyle
    • Local
    • Lowcountry News
    • National
    • National Opinion
    • News
    • Politics
    • Real Estate
    • Senior Living
    • Sports
    • State
    • Tech
    • Traffic
    • Transportation
    • Travel
    • Weather
    • World
    Savannah Herald Newsletter

    Subscribe to Updates

    A round up interesting pic’s, post and articles in the C-Port and around the world.

    About Us
    About Us

    The Savannah Herald is your trusted source for the pulse of Coastal Georgia and the Low County of South Carolina. We're committed to delivering timely news that resonates with the African American community.

    From local politics to business developments, we're here to keep you informed and engaged. Our mission is to amplify the voices and stories that matter, shining a light on our collective experiences and achievements.
    We cover:
    🏛️ Politics
    💼 Business
    🎭 Entertainment
    🏀 Sports
    🩺 Health
    💻 Technology
    Savannah Herald: Savannah's Black Voice 💪🏾

    Our Picks

    Vacation disagreements with your bigoted uncle

    December 5, 2025

    In Benin, malnutrition and misinformed views contribute to widespread stunting in children

    August 22, 2026

    If We Stop Counting, Who Disappears?

    September 8, 2026

    ‘Hospice care saved my life’ – Dublin dad as coffee morning launched

    August 7, 2026

    Selling a Foreclosure House in Augusta, GA: What to Know

    September 29, 2026
    Categories
    • Art & Literature
    • Beauty
    • Black History
    • Business
    • Climate
    • Culture
    • Education
    • Employment
    • Entertainment
    • Faith
    • Fashion
    • Food
    • Gaming
    • Georgia Politics
    • Guides
    • HBCUs
    • Health
    • Health Inspections
    • Investing
    • Lifestyle
    • Local
    • Lowcountry News
    • National
    • National Opinion
    • News
    • Politics
    • Real Estate
    • Senior Living
    • Sports
    • State
    • Tech
    • Traffic
    • Transportation
    • Travel
    • Weather
    • World
    Copyright © 2002-2026 Savannahherald.com All Rights Reserved. A Veteran-Owned Business

    Type above and press Enter to search. Press Esc to cancel.

    Manage Consent
    To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
    Functional Always active
    The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
    Preferences
    The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
    Statistics
    The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
    Marketing
    The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
    • Manage options
    • Manage services
    • Manage {vendor_count} vendors
    • Read more about these purposes
    View preferences
    • {title}
    • {title}
    • {title}
    Ad Blocker Enabled!
    Ad Blocker Enabled!
    Our website is made possible by displaying online advertisements to our visitors. Please support us by disabling your Ad Blocker.

    Sign In or Register

    Welcome Back!

    Login to your account below.

    Lost password?